Why bEVs Outperform Whole Bacterial Cells as biologicals
Comparison whole bacterial cells vs bEVs
🦠 Whole Bacterial Cells (Conventional biologicals)
-
Living organisms → unpredictable behavior in the field
-
Depend on survival, colonization, and environmental conditions
-
Delayed mode of action (require growth and metabolite production)
-
Bioactive compound release is inconsistent and context-dependent
-
Broad and indirect effects on target organisms
-
Risk of ecological imbalance and horizontal gene transfer
-
Sensitive to UV, temperature, and desiccation
-
Limited stability and shelf-life
-
More complex and slower regulatory approval pathways
-
Difficult to engineer and control functional output
🧬bEVs (EVerse Technology)
-
Cell-free system → highly controlled and reproducible
-
Do not require survival or colonization
-
Immediate biological activity upon application
-
Pre-loaded with defined bioactive cargo (proteins, metabolites, RNA)
-
Targeted and efficient delivery to pests or pathogens
-
Non-replicative → improved biosafety profile
-
More stable and easier to formulate and store
-
Reduced variability → consistent performance in the field
-
Potentially simplified regulatory pathway
-
Engineerable platform technology for multiple applications
Applications
Precision agriculture solutions
-
Insect pest control
bEVs enable targeted delivery of insecticidal proteins and metabolites, improving efficacy while minimizing harm to non-target organisms.
-
Delivery of bioactive molecules
Our vesicle-based systems transport toxins, enzymes, and secondary metabolites with enhanced stability and bioavailability.
-
RNA & Gene editing delivery
bEVs can carry nucleic acids, enabling gene regulation strategies in plant pathogens and pests for advanced crop protection.
-
Plant growth promotion
bEVs deliver signaling molecules and beneficial factors that enhance plant growth, stress tolerance, and nutrient efficiency.